Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Musculoskeletal  |  Neurology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (609) clinical trials

Now recruiting for a clinical study in patients with Parkinson's disease. Do you, or someone you know, have Parkinson's disease? Patient volunteers are needed for the Galliarde Study, a clinical research study to evaluate the safety of and how well the body handles ABBV-951. ABBV-951 is an investigational product that ...

Phase N/A

To evaluate the safety and efficacy of IPX203 (carbidopa and levodopa) extended-release capsules (IPX203 ER CD-LD) in comparison to immediate release (IR) CD-LD in the treatment of CD-LD-experienced subjects with Parkinson's disease (PD) who have motor fluctuations.  

Phase

This is a randomized, double-blind, placebo-controlled study to assess the safety and tolerability of GRF6021, a 5% human plasma protein fraction, administered by intravenous (IV) infusion to subjects with Parkinson’s disease (PD) and cognitive impairment.  

Phase

A research study is evaluating an investigational medication that may reduce the rate of progression in the early stages of Parkinson’s disease (PD).  

Phase N/A

18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety

Single centre prospective cohort phase III study of 18F-DOPA PET/CT imaging in specific patient populations: Pediatric patients with congenital hyperinsulinism Pediatric patients with neuroblastoma Pediatric or Adult patients with suspected extra-pancreatic neuroendocrine tumor Adult patients with a clinical suspicion of Parkinson's disease Pediatric or Adult patients with primary brain tumors ...

Phase

Help-seeking for Health Problems in People With Parkinson's

Non-motor symptoms (NMS) are common in Parkinson's disease (PD) and cause significant distress and decreased quality of life. A high rate of non-declaration of NMS by patients means that many NMS remain unrecognized and untreated, even in specialist clinical services. In phase one of this research qualitative interviews (phase 1) ...

Phase N/A

Effect of Acetylcholinesterase Inhibitors on the Gait of the Patients With Parkinson Disease

PD patients with PIGD subtype will be included. Assessment: Overall features of PD are assessed by Unified Parkinson Disease Rating Scale (UPDRS). Non-motor features including cognition will be assessed by standard scales. Gait and balance will be assessed by gait analysis system, which measures physiological parameters of gait such as ...

Phase

Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease

Parkinson's disease (PD) is one of the most common neurodegenerative diseases, with a higher prevalence in the elderly. Levodopa induced dyskinesias (LID) are a major motor complications that impair quality of life for patients with PD. The mechanisms of these dyskinesias remain unclear, but several hypotheses have been put forward: ...

Phase

In Vivo Alzheimer Proteomics

In France, an estimated 860 000 patients are affected by Alzheimer Disease (AD) which represents, as in other developed countries, a major public health issue. In many cases, AD diagnosis is uncertain and its clinical evolution unpredictable. The exactitude of the diagnosis is however particularly important in the perspective of ...

Phase N/A